www.fdanews.com/articles/122595-templeton-backs-sun-pharmaceutical-bid-for-taro
Templeton Backs Sun Pharmaceutical Bid for Taro
December 2, 2009
Mark Mobius, chairman of Templeton Asset Management Ltd., backed Sun Pharmaceuticals
Ltd.’s year-long bid to buy Israeli drugmaker
Taro Pharmaceutical Industries Ltd., saying he wants the deal completed “as fast as possible.”
Bloomberg
Bloomberg